On March 17, 2011, the International Myeloma Foundation (IMF) established the Asian Myeloma Network (AMN) at a meeting in Singapore. Composed of myeloma experts from China, Hong Kong, Taiwan, Japan, South Korea, Singapore, and Thailand, the IMF Asian Myeloma Network—the first of its kind in the region—has taken the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Myeloma is a growing health problem in Asia, with an incidence that is approaching that in Western countries, but with a much larger population base.
Since its founding, the AMN has:
- Created a unified data base to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies
- Launched and overseen clinical trials
- Enabled myeloma patients to gain access to the newest myeloma treatments
- Developed informational resource materials in local languages, especially for patients and care givers
- Engaged in collaborative studies